| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Fucoxanthin | Alcoholic Liver Disease | 1 | PM | 31569771 | 📋 | Protective Effects of Fucoxanthin against Alcoholic Liver Injury by Activation of Nrf2-Mediated Antioxidant Defense and Inhibition of TLR4-Mediated Inflammation |
| Fucoxanthin | Hepatic Fibrosis | 3 | PM | 38204245 | 📋 | Fucoxanthin Enhances the Antifibrotic Potential of Placenta-derived Mesenchymal Stem Cells in a CCl4-induced Mouse Model of Liver Fibrosis |
| Fucoxanthin | Hepatic Fibrosis | 2 | PM | 37391684 | 📋 | Fucoxanthin exert dose-dependent antifibrotic and anti-inflammatory effects on CCl4-induced liver fibrosis |
| Fucoxanthin | Hepatic Fibrosis | 1 | PM | 30982574 | 📋 | Fucoxanthin exerts anti-fibrogenic effects in hepatic stellate cells |
| Fucoxanthin | Hepatic Steatosis | 2 | PM | 33809062 | 📋 | Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis |
| Fucoxanthin | Hepatic Steatosis | 1 | PM | 29113798 | 📋 | Fucoxanthin attenuates fatty acid-induced lipid accumulation in FL83B hepatocytes through regulated Sirt1/AMPK signaling pathway |
| Fucoxanthin | Hepatotoxicity | 2 | PM | 37999416 | 📋 | Antioxidative and Anti-Inflammatory Protective Effects of Fucoxanthin against Paracetamol-Induced Hepatotoxicity in Rats |
| Fucoxanthin | Hepatotoxicity | 1 | PM | 37504922 | 📋 | Protective Effect of Fucoxanthin on Zearalenone-Induced Hepatic Damage through Nrf2 Mediated by PI3K/AKT Signaling |
| Fucoxanthin | Liver Cancer | 1 | PM | 30379338 | 📋 | Protective role of fucoxanthin in diethylnitrosamine-induced hepatocarcinogenesis in experimental adult rats |
| Fucoxanthin | Liver Cancer | 4 | PM | 19737546 | 📋 | Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional intercellular communication |
| Fucoxanthin | Liver Cancer | 2 | PM | 18230364 | 📋 | Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D |
| Fucoxanthin | Liver Cancer | 3 | PM | 17436581 | 📋 | Fucoxanthin, a natural carotenoid, induces G1 arrest and GADD45 gene expression in human cancer cells |
| Fucoxanthin | MAFLD | 5 | PM | 38669300 | 📋 | Molecular Mechanisms of Fucoxanthin in Alleviating Lipid Deposition in Metabolic Associated Fatty Liver Disease |
| Fucoxanthin | MAFLD | 4 | PM | 37175909 | 📋 | The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease |
| Fucoxanthin | MAFLD | 3 | PM | 37111187 | 📋 | A Review of the Effects of Fucoxanthin on NAFLD |
| Fucoxanthin | MAFLD | 2 | PM | 35447899 | 📋 | Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4 Signaling Pathway |
| Fucoxanthin | MAFLD | 1 | PM | 33809062 | 📋 | Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis |
| Fucoxanthin | Non-Alcoholic Steatohepatitis | 1 | PM | 32475638 | 📋 | Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice |
